BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17540213)

  • 1. Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Sugioka K; Hozumi T; Takemoto Y; Ehara S; Ogawa K; Iwata S; Oe H; Matsumura Y; Otsuka R; Yoshiyama M; Yoshikawa J
    Am Heart J; 2007 Jun; 153(6):1080.e1-6. PubMed ID: 17540213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of carvedilol therapy on coronary flow reserve in patients with idiopathic dilated cardiomyopathy.
    Calişkan M; Ciftçi O; Güllü H; Müderrisoğlu H
    Turk Kardiyol Dern Ars; 2008 Jun; 36(4):247-52. PubMed ID: 18765968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of carvedilol on coronary flow reserve in patients with dilated cardiomyopathy].
    Fan Y; Lin JH; Dong G; Zhu J; Yin F; Yang SS
    Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):217-9. PubMed ID: 20450653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
    Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
    J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
    J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment.
    Kawai K; Hata K; Takaoka H; Kawai H; Yokoyama M
    Am Heart J; 2001 Jun; 141(6):925-32. PubMed ID: 11376305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Tange S; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Nov; 45(11):1878-84. PubMed ID: 15534058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
    Kaya MG; Sarli B; Akpek M; Kaya EG; Yarlioglues M; Topsakal R; Lam YY
    Cardiol J; 2014; 21(4):434-41. PubMed ID: 24142686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of coronary flow reserve and left ventricular remodeling in a mouse model of chronic aortic regurgitation with carvedilol intervention.
    Wang X; Wu J; Zhu D; You J; Zou Y; Qian J; Ge J
    J Ultrasound Med; 2015 Mar; 34(3):483-93. PubMed ID: 25715369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of coronary flow reserve for left ventricular functional improvement after cardiac resynchronization therapy in patients with dilated cardiomyopathy.
    Djordjevic Dikic A; Nikcevic G; Raspopovic S; Jovanovic V; Tesic M; Beleslin B; Stepanovic J; Giga V; Milasinovic G
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1344-9. PubMed ID: 25053732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of carvedilol to abolish myocardial postsystolic shortening in patients with idiopathic dilated cardiomyopathy.
    Ito T; Kawanishi Y; Futai R; Terasaki F; Kitaura Y
    Am J Cardiol; 2009 Dec; 104(11):1568-73. PubMed ID: 19932794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effect of esmolol intravenously on coronary microcirculation in patients with idiopathic dilated cardiomyopathy.
    Skalidis EI; Hamilos MI; Chlouverakis G; Kochiadakis GE; Parthenakis FI; Vardas PE
    Am J Cardiol; 2007 Oct; 100(8):1299-302. PubMed ID: 17920374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.
    Rahko PS
    Echocardiography; 2005 Aug; 22(7):547-54. PubMed ID: 16060890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early recovery of impaired coronary flow reserve by carvedilol therapy in patients with idiopathic dilated cardiomyopathy: a serial transthoracic Doppler echocardiographic study.
    Sugioka K; Hozumi T; Takemoto Y; Ujino K; Matsumura Y; Watanabe H; Fujimoto K; Yoshiyama M; Yoshikawa J
    J Am Coll Cardiol; 2005 Jan; 45(2):318-9. PubMed ID: 15653035
    [No Abstract]   [Full Text] [Related]  

  • 16. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral endothelial function may predict the effectiveness of beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Xie X; Wu B; Chen Y; Li W; Hu X; Chen J
    Int J Cardiol; 2016 Oct; 221():128-33. PubMed ID: 27400309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
    Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F
    J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gated myocardial SPECT to predict response to beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Fukuchi K; Yasumura Y; Kiso K; Hayashida K; Miyatake K; Ishida Y
    J Nucl Med; 2004 Apr; 45(4):527-31. PubMed ID: 15073245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy.
    Neglia D; De Maria R; Masi S; Gallopin M; Pisani P; Pardini S; Gavazzi A; L'abbate A; Parodi O
    Heart; 2007 Jul; 93(7):808-13. PubMed ID: 17237134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.